TD Asset Management’s Q32 Bio QTTB Stock Holding History
Bought
Maintained
Sold
Other funds holding QTTB
5VM
BG
VC
VVA
TD Asset Management's QTTB Position: Q1 2022 in Review
TD Asset Management sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 1,883 shares — an estimated $123K sold.
TD Asset Management first reported a position in QTTB in Q1 2018 and held it in 16 quarters. The position peaked at $1.35M in Q4 2019. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.
- TD Asset Management reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
- TD Asset Management sold 1,883 Q32 Bio shares in Q1 2022, an estimated $123K.
- TD Asset Management first reported a position in Q32 Bio in Q1 2018 and held it in 16 quarters.
- TD Asset Management's Q32 Bio position peaked at $1.35M in Q4 2019.
- 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.
Based on TD Asset Management's 13F filing for Q1 2022, filed 10 May 2022.